Trial
NCT02332928
Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Virginia Commonwealth University
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer - Female
Intervention
Melatonin
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-30